Treatment indication, n (%)
Risk of functional impairment
Discomfort due to ulceration
Cosmetic disfigurement
|
61 (18.3%)
47 (13.9%)
229 (67.8%)
|
Age of propranolol initiation
months
1-2 months
3-6 months
6-12 months
>12 months
|
10 (2.9%)
79 (23.2%)
151 (44.4%)
66 (19.4%)
34 (10%)
|
Propranolol dosage
1 mg/kg/d
2 mg/kg/d
2.5 mg/kg/d
4 mg/kg/d
|
3 (0.9%)
332 (97.6%)
4 (1.2%)
1 (0.3%)
|
Total length of propranolol treatment, mean (range) [SD]
<3 weeks
3-6 weeks
6-12 weeks
3-6 months
>6 months
|
10.71 (0.5 to 44) [6.41]
2 (0.6%)
4 (1.2%)
13 (3.8%)
87 (25.6%)
234 (68.8%)
|
Propranolol Response
None
Partial
Nearly Complete
Complete
Missing
|
10 (2.9%)
59 (17.5%)
174 (51.5%)
95 (28.1%)
2 (4.0%)
|
Second cycle of propranolol after initial cycle was stopped |
14
(4.3%) |
Propranolol Adverse Events
Hypoglycemia
Bronchospasm
Irritability/agitation
Vomiting
Diarrhea
Fatigue
|
21 (6.2%)
2 (9.5%)
2 (9.5%)
8 (38.1%)
1 (4.8%)
2 (9.5%)
6 (28.6%)
|
Laser Therapy, n (%) |
24 (7.3%) |
Surgical Excision, n (%) |
32 (9.8%) |
Corticosteroid Treatment, n (%) |
12 (3.7%) |